ACRES Commercial Realty Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACR research report →
Range $15 – $24.5
Price Chart
About the company
ACRES Commercial Realty Corp. (ACR) functions as a real estate investment trust (REIT) based in Uniondale, New York, having been established in 2005. The firm's primary objective is to generate, own, and administer various debt instruments related to commercial real estate, including mortgage loans, throughout the United States.
- CEO
- Mark Steven Fogel
- IPO
- 2006
- Employees
- 4
- HQ
- Uniondale, NY, US
Get TickerSpark's AI analysis on ACR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $104.26M
- P/E
- -13.54
- Fwd P/E
- 46.66
- PEG
- 0.00
- P/S
- 0.56
- P/B
- 0.24
- EV/EBITDA
- 31.77
- Div Yield
- 0.00%
- Gross Margin
- 72.19%
- Op Margin
- 25.65%
- Net Margin
- 7.49%
- ROE
- 3.31%
- ROIC
- 1.99%
Latest fiscal year · YoY change
- Revenue
- $165.90M+98.7%
- Gross Profit
- $159.34M+335.4%
- Op Income
- $102.39M
- Net Income
- $21.32M-27.2%
- EPS
- $0.03-97.2%
- OCF Growth
- -78.8%
- FCF Growth
- -79.7%
- 52W High
- $24.61
- 52W Low
- $13.83
- 50D MA
- $16.84
- 200D MA
- $19.45
- Beta
- 1.09
- RSI (14)
- 36
- Avg Volume
- 35.12K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
ACRES reported a Q2 loss driven largely by internalization costs, while management said the portfolio is improving, pipeline activity is strong, and the planned internalization is close to closing.· July 30, 2026
- GAAP net loss allocable to common shares was $12.5 million, or $1.87 per share, mainly due to internalization-related costs and accelerated vesting expense.
- EAD was a loss of $0.74 per share; management said it would have been a gain of $0.14 per share without transaction-related costs and deferred debt cost acceleration.
- Book value per share fell to $26.76 from $29.98 at March 31, with liquidity at $83 million and leverage down to 3.2x from 3.4x.
- Management reiterated its 2026 goal of $500 million in net growth and said the pipeline is “stronger than ever.”
- Shareholders overwhelmingly approved the internalization transaction, and management expects the closing to happen in short order, with lower one-time expenses in Q3 than Q2.
GAAP net loss allocable to common shares in Q2 2026 was $12.5 million, or $1.87 per share. EAD was a loss of $0.74 per share versus a gain of $0.02 per share in Q1; management said EAD would have been $0.14 per share excluding transaction-related costs and deferred debt cost acceleration. GAAP net interest income was $10.5 million, up $1.3 million from the prior quarter, driven mainly by the full-quarter impact of the new CRE securitization. GAAP book value per share was $26.76 at June 30 versus $29.98 at March 31; liquidity was $83 million, including $41 million of unrestricted cash and $42 million of projected financing available on unlevered assets. The allowance for credit losses was $21.1 million, or 0.99% of the $2.1 billion loan portfolio at par, and leverage fell to 3.2x from 3.4x. For the loan portfolio, payoffs and paydowns were $92.7 million and funded commitments were $17.8 million, resulting in a net decrease of $74.9 million. Management still expects to meet its target of $500 million in net REIT growth for 2026. For Q3, management said additional transaction-related costs will be recognized, but those one-time expenses will be lower than in Q2.
Mark Steven Fogel said the portfolio continues to be actively managed and is improving on underperforming assets, while underwriting remains selective. He emphasized that the market is showing more capitulation, which is creating opportunities to buy or originate loans backed by quality sponsors. He also highlighted that the internalization is progressing and that the company expects to provide more updates as it gets completed.
Eldron C. Blackwell focused on the quarter’s accounting impacts and balance sheet position. He cited $5.1 million of internalization transaction costs, $4 million of incremental compensation expense from accelerated vesting, and $984 thousand of accelerated deferred debt costs, all of which pressured earnings and EAD. He also pointed to $83 million of available liquidity, a $21.1 million allowance for credit losses, and a reduction in leverage to 3.2x, while noting that additional transaction costs should flow through Q3 as the deal closes.
Analysts focused on the path to the $500 million net growth target, the internalization expense run-rate, the drivers of post-merger AUM fees, and the timeline for selling remaining REO assets. Management said the pipeline is stronger than ever and that growth should come from converting existing equity dollars in the portfolio into loan book, not primarily from warehouse financing. On fees, management pointed to evergreen funds, separate accounts, and new fund products, saying AUM growth would push fee income higher. On the remaining hotel REO, management said it is back on the market but remains difficult to sell because labor issues make expense forecasting hard.
The positive case from this call is that management believes the pipeline is very strong and is seeing more distressed capitulation, which could create attractive origination and acquisition opportunities. The internalization received about 99% approval and management said closing should happen soon, potentially simplifying the business and aligning employees with shareholders.
The main pressure point is that earnings and book value were hit by internalization-related costs, accelerated vesting expense, and deferred debt cost acceleration. Credit risk is still present: the weighted average risk rating ticked up to 2.6 from 2.5, loans rated 4 or 5 stayed at 10, and 14% of the CRE loan portfolio was still rated 4 or 5 by economic value. Management also acknowledged that one REO hotel remains difficult to sell because of labor-union uncertainty, and more transaction costs are expected in Q3.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.2%
- Shares Outstanding
- 7.13M
- Float Shares
- 6.36M
of shares held by institutions
65 13F filers
Buy/sell ratio 1.15. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Eagle Point Credit Management LLC | 1.18M | 0 |
| Blackrock, Inc. | 452.33K | ▲ 1.60K |
| Vanguard Group Inc | 378.26K | ▼ 5.44K |
| Vanguard Capital Management LLC | 252.20K | ▼ 52.78K |
| Nokomis Capital, L.L.C. | 145.77K | ▼ 41.52K |
| Geode Capital Management, LLC | 140.04K | ▼ 4.06K |
| Acadian Asset Management LLC | 120.92K | ▼ 23.50K |
| Mink Brook Asset Management LLC | 101.62K | ▲ 9.19K |
| State Street Corp | 89.55K | ▼ 568 |
| Punch & Associates Investment Management, Inc. | 72.27K | ▲ 72.27K |
| Janney Montgomery Scott LLC | 46.81K | ▲ 535 |
| Northern Trust Corp | 44.64K | ▼ 19.32K |
Held by 74 ETFs
Biggest fund positions in ACR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 6, 26 | Fogel Mark S | other | 1,440,552 |
| Aug 6, 26 | Kilpatrick Linda M | other | 3,928 |
| Aug 6, 26 | NEFF P SHERRILL | other | 4,280 |
| Aug 6, 26 | KESSLER STEVEN J | other | 2,568 |
| Aug 6, 26 | Jesberger Jaclyn | other | 343,856 |
| Aug 6, 26 | Ickowicz Gary | other | 2,568 |
| Aug 6, 26 | Edwards Karen K | other | 2,568 |
| Aug 6, 26 | Blackwell Eldron C | other | 7,856 |
| Aug 6, 26 | Brengel Kyle K. | other | 309,675 |
| Aug 6, 26 | Fentress Andrew | other | 988,453 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ACR coverage
Recent articles, reports, and earnings notes.
No research on ACR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACR report →CORRECTING and REPLACING Amid Declining Book Value, ACRES Commercial Realty Struggles to Sell REO Property Due to Labor Dispute with Philadelphia Hospitality Union UNITE HERE Local 274
businesswire.com · Aug 20
ACRES COMMERCIAL REALTY CORP. ANNOUNCES COMPLETION OF MERGER, INTERNALIZATION AND PRIVATE NOTES OFFERING
prnewswire.com · Aug 6
Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
globenewswire.com · Aug 5
ACRES Commercial Realty: Why We Are Staying Neutral On ACRES Series C Preferred
seekingalpha.com · Jul 31
ACRES Commercial Realty Corp. (ACR) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 30
ACRES Commercial (ACR) Reports Q2 Loss, Misses Revenue Estimates
zacks.com · Jul 29
ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR SECOND QUARTER 2026
prnewswire.com · Jul 29
Implied Volatility Surging for ACRES Commercial Stock Options
zacks.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.